Concepedia

Publication | Open Access

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

DOIFull Paper Access

38

Citations

23

References

2021

Year

Maaike Biewenga, Monique K. van der Kooij, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Jan Willem B. de Groot, Marye J. Boers‐Sonderen, Geke A.P. Hospers, Djura Piersma, Rozemarijn S. van Rijn,
Hepatology International

Abstract

Incidence of hepatitis in a real-world cohort is 1.8% for PD-1 inhibitor, 2.6% for ipilimumab and 20.7% for combination therapy. Checkpoint inhibitor-induced hepatitis had no relation with liver metastasis and had no negative effect on the outcome.

References

YearCitations

Page 1